Industry News
Boston Scientific Begins U.S. and International Launch of WallFlex Biliary Transhepatic Stent System
NATICK, Mass., March 22, 2012 /PRNewswire via COMTEX/ -- Boston Scientific Corporation BSX -0.33% announces the U.S. and international launch of the WallFlex® Biliary Transhepatic Stent System. This third-generation stent platform is now available with a percutaneous delivery system designed for use by interventional radiologists in the palliative treatment of biliary strictures produced by malignant tumors. The WallFlex Biliary Transhepatic Fully Covered Stent System is also available for the treatment of benign biliary strictures in CE marked countries.
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts. The acquisition is subject to customary closing conditions.
iBGStar Blood Glucose Meter Attachment For The iPhone
iBGStar blood glucometer attachment for the iPhone, developed by AgaMatrix and commercialized by Sanofi, has received FDA approval. The iBGStar uses the iPhone as visualization tool to keep track of glucose readings, food and insulin intake, and exercise.
The device can be used independently of the iPhone to take readings and data will be transferred to the iPhone once the two are connected again.
The device has gone on sale in some EU countries earlier this year and American launch is expected shortly.
Medtronic Announces Physio Control Sold to Bain Capital
Physio-Control is being sold to Bain Capital for $487 million, parent company Medtronic announced Thursday morning.
The all-cash deal follows five years of uncertainty for Physio-Control, best known for the Lifepak emergency defibrillators used by ambulance crews and other first responders to treat cardiac arrest. Medtronic originally proposed spinning off Physio as a public company in December 2006, but quality-control problems a few months later torpedoed that plan.
Atrium Medical has signed definitive agreement to be acquired by Getinge Group
MAQUET Cardiovascular, a global leading provider of cardiovascular technologies, announced today that it has signed a definitive agreement to acquire Atrium Medical Corporation for $680 million. Atrium is a leader in medical device technologies for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Atrium will operate as an independent, self-contained business unit of MAQUET Cardiovascular and will be led by current Atrium president, Trevor Carlton.
Cardiac Dimensions wins CE mark approval for its Carillon Mitral Contour System
Ethicon Endo-Surgery to acquire SterilMed
Ethicon Endo-Surgery (EES), a Johnson & Johnson company, has entered into an definitive agreement to acquire SterilMed. The acquisition allows SterilMed to be a part of the Ethicon Endo-Surgery franchise and it will continue to operate as a standalone company and retain the name SterilMed.
FDA Approval For Melafind
MELA Sciences Receives FDA Approvable for MelaFind
St Jude Medical Announces European Launch of Smaller Quadripolar Pacing System
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the European launch of the Unify Quadra(TM) cardiac resynchronization therapy defibrillator (CRT-D). The Unify Quadra CRT-D works with the company's Quartet(TM) left ventricular pacing lead. The combined system offers physicians the ability to effectively and efficiently manage the changing pacing needs of patients with heart failure with a downsized quadripolar pacing system.
Cellnovo receives CE mark approval for world's first mobile diabetes management system
Cellnovo, developer of the first mobile diabetes management system, announced today that it raised ₤30 million ($48.4 million) in a Series B financing round led by Edmond de Rothschild Investment Partners (EdRIP), with Forbion Capital Partners; Auriga Partners; NBGI Ventures and Credit Agricole Private Equity joining Series A
investors Advent Venture Partners, HealthCare Ventures and NESTA in the round.
